Acute myocardial infarction in patients with end-stage renal disease. Kidney Int Suppl. 1999;71:S130 3. 43. Reddan DN, Szczech L, Bhapkar MV, et al. Renal function, concomi- tant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant. 2005;20:2105 12. 44. Shlipak MG, Heidenreich PA, Noguchi H, et al. Association of renal in- sufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555 62. 45. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angio- tensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol. 2003;42:201 8. 46. Medi C, Montalescot G, Budaj A, et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv. 2009;2:26 33. 47. Tsai TT, Maddox TM, Roe MT, et al. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA. 2009;302:2458 64. 48. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myo- cardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909 45. 49. Mehta RH, Califf RM, Garg J, et al. The impact of anthropomorphic in- dices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J. 2007;28:415 24. 50. Goldberg RJ, Spencer FA, Fox KAA, et al. Prehospital delay in patients with acute coronary syndromes (from the Global Registry of Acute Coro- nary Events [GRACE]). Am J Cardiol. 2009;103:598 603. 51. Spencer FA, Montalescot G, Fox KAA, et al. Delay to reperfusion in pa- tients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J. 